Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Experts address mechanisms, link between cognitive decline and diabetes
• AACE releases consensus statement on detection of lipodystrophy
• AHA: Gaps in CVD awareness persist among women
• America’s graduate medical education programs in jeopardy, fellows speak out
• CBO lowers estimate for 10-year freeze of payments under the SGR
• CMS issues final rule on Physician Payment Sunshine Act
• Efficacy of genetic testing for familial hypercholesterolemia questioned
• EndoBarrier trial to begin in US
• NIH plans HAPO follow-up study
• Smoking influenced link between physical activity, age of menopause
• USPSTF: Insufficient evidence on vitamin D, calcium supplementation
• WHO, UN release joint report on endocrine disrupting chemicals
• FDA: More CV data needed on Tresiba, Ryzodeg before approval
• FDA advisory panel recommends against two drugs for vasomotor symptoms
• Ectopic carotid sheath parathyroid adenoma found in 56-year-old male Stephanie L. Lee, MD, PhD, ECNU
• Early mortality among young adults linked to cardiometabolic risk factors
• Active lifestyle appears as beneficial as structured exercise
• Age increased risk for obesity-related mortality among US adults
• Blood clots may increase white matter hyperintensities after menopause
• CABG may be preferable to DES in patients with diabetes, CAD
• Closed-loop system reduced hypoglycemia, improved glycemic control
• Eating late could hinder weight loss
• Exogenous insulin increased risk for complications, mortality in type 2 diabetes
• Exposure to c-hGH did not increase risk for Alzheimer’s, Parkinson’s
• Father’s obesity may increase newborn’s risk for cancer later in life
• Firstborns may be at higher risk for metabolic, CV diseases
• GLP-1 agents led to more frequent pancreatitis hospitalization
• GLP-1 therapy shows promise for severely obese adolescents
• High bone mass linked to greater fat mass in women
• Impaired health status of CAH acquired, not determined
• Maternal exposure to air pollutants led to low birth weight
• Medicaid drug selection committees often mismanage COI policies, researchers say
• Melanocortin 4 receptor agonists activate obesity-related hypertension
• NIH: HbA1c, BP, LDL levels still suboptimal for many with diabetes
• NIH: Molecular link found between metabolism, breast cancer
• Omega-6 linoleic acid supplements may be harmful in heart disease
• Pollutants in food, air, water increased risk for type 2 diabetes
• Researchers address obesity myths
• Selumetinib increased radioiodine uptake in thyroid cancer
• Steroids increased risk for CVD, mortality in patients with Cushing’s disease
• Vasomotor symptoms decreased quality of life in postmenopausal women
• Shortened hormone therapy did not reduce survival of patients with high-risk prostate cancer
• Alogliptin: Latest DPP-IV in the clinician’s 
armamentarium for type 2 diabetes James R. Taylor, PharmD, CDE